These findings suggest that inadequate DHA intake or chronically low consumption may have disproportionate implications for brain structure and function, particularly in populations with limited dietary access to DHA-rich foods
Therefore, although it is currently reported in the literature that 50% of patients with rhabdomyolysis will not complain of muscle pain or weakness, and less than 10% of patients will have typical symptoms ( Vildagliptin is a DPP-4 inhibitor, which is rare to induce rhabdomyolysis compared with traumatic causes ( Generally, intravenous fluid therapy is the cornerstone of treatment
Submitted: August 11, 2024
Levy G, Garrettson LK, Soda DM
Many patients report changes within 4-8 weeks, with continued improvement over several months
Nesss testimony is allowed and their case progresses, it could reignite the debate about Tylenols safety during pregnancy